Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -10.00% | -18.18% | +24.14% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.14% | 349M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.66% | 22.2B | |
-16.53% | 21.23B | |
-9.26% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics : Names Brian DeSchuytner Chief Financial Officer